Asset Management One
MRNA icon

Asset Management One’s Moderna MRNA Stock Holding History

Asset Management One’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.47M Buy
21,002
+4,274
+26% +$221K ﹤0.01% 725
2026
Q1 		$850K Sell
16,728
-1,091
-6% -$50.9K ﹤0.01% 754
2025
Q4 		$555K Sell
17,819
-500
-3% -$13.6K ﹤0.01% 798
2025
Q3 		$473K Buy
18,319
+4,985
+37% +$139K ﹤0.01% 807
2025
Q2 		$368K Sell
13,334
-116,991
-90% -$3.08M ﹤0.01% 821
2025
Q1 		$3.69M Buy
130,325
+7,274
+6% +$258K 0.01% 664
2024
Q4 		$4.94M Buy
123,051
+1,381
+1% +$66K 0.02% 616
2024
Q3 		$8.13M Buy
121,670
+1,159
+1% +$106K 0.03% 477
2024
Q2 		$14.3M Sell
120,511
-1,078
-0.9% -$136K 0.05% 320
2024
Q1 		$13M Sell
121,589
-8,957
-7% -$903K 0.05% 356
2023
Q4 		$12.9M Sell
130,546
-2,801
-2% -$236K 0.05% 357
2023
Q3 		$13.8M Buy
133,347
+801
+0.6% +$89.3K 0.06% 323
2023
Q2 		$16.1M Sell
132,546
-2,469
-2% -$329K 0.07% 294
2023
Q1 		$20.7M Buy
135,015
+2,734
+2% +$451K 0.09% 217
2022
Q4 		$23.7M Sell
132,281
-8,595
-6% -$1.41M 0.12% 183
2022
Q3 		$16.7M Sell
140,876
-3,305
-2% -$501K 0.08% 240
2022
Q2 		$20.6M Sell
144,181
-2,523
-2% -$361K 0.1% 209
2022
Q1 		$25.3M Sell
146,704
-7,053
-5% -$1.19M 0.1% 204
2021
Q4 		$38.1M Sell
153,757
-602
-0.4% -$176K 0.13% 151
2021
Q3 		$59.4M Buy
154,359
+14,360
+10% +$5.3M 0.23% 88
2021
Q2 		$32.9M Buy
139,999
+13,007
+10% +$2.32M 0.12% 173
2021
Q1 		$16.6M Sell
126,992
-498
-0.4% -$72.2K 0.07% 322
2020
Q4 		$14.5M Sell
127,490
-1,658
-1% -$168K 0.06% 334
2020
Q3 		$9.14M Sell
129,148
-6,596
-5% -$460K 0.04% 415
2020
Q2 		$8.72M Buy
+135,744
New +$7.43M 0.04% 404

Other funds holding MRNA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.68B AUM 19.9% 1-Year Est. Return

Asset Management One's MRNA Position: Q2 2026 in Review

Asset Management One increased its Moderna (MRNA) stake by 26% in Q2 2026, buying an estimated $221K and bringing the position to 21,002 shares worth $1.47M. The position accounts for ﹤0.01% of the portfolio, ranked #725.

Asset Management One first reported a position in MRNA in Q2 2020 and has held it in 25 quarters since. The position peaked at $59.4M in Q3 2021. 782 funds tracked by Wall St. Rank hold MRNA as of Q2 2026.

  • Asset Management One held 21,002 shares of Moderna worth $1.47M as of Q2 2026.
  • Asset Management One bought 4,274 Moderna shares in Q2 2026, an estimated $221K.
  • Moderna made up ﹤0.01% of Asset Management One's portfolio in Q2 2026, its #725 holding.
  • Asset Management One first reported a position in Moderna in Q2 2020 and has held it in 25 quarters since.
  • Asset Management One's Moderna position peaked at $59.4M in Q3 2021.
  • 782 funds tracked by Wall St. Rank held Moderna as of Q2 2026.

Based on Asset Management One's 13F filing for Q2 2026, filed 28 Jul 2026.